A security committee with Europe’s regulator concluded AstraZeneca’s COVID-19 vaccine is protected and efficient, with no ties to an total elevated threat of blood clots in vaccinated people. However, a definitive hyperlink to critical blood issues couldn’t be dominated out.
Top officers with the European Medicines Agency mentioned the advantages of the vaccine towards COVID-19 and its related hospitalizations and deaths proceed to exceed the dangers of negative effects.
“PRAC [the safety committee] famous the variety of thromboembolic occasions reported after vaccination is decrease than the anticipated within the common inhabitants and PRAC has concluded that there isn’t any improve within the total threat of blood clots with this vaccine,” mentioned Dr. Sabine Straus, chair of the security committee.
Germany, France, Italy and Spain joined the rising listing of largely European nations — beginning with Denmark final week — that quickly halted using the AstraZeneca vaccine in latest days to analyze instances of blood clots that occurred after vaccination. Others embody Thailand and Congo.
Many nations with paused vaccinations had been hinging on a conclusion from regulators.
The Associated Press contributed to this report.
This is a growing story, please test again for updates.